Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
X
Xenon Pharmaceuticals Inc
F:XP0
Xenon Pharmaceuticals Inc
F:XP0
Price:
31.2
EUR
-3.11%
Market Cap:
€2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X
|
Xenon Pharmaceuticals Inc
F:XP0
|
CA |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
|
Pearson PLC
LSE:PSON
|
UK |
|
Genesis Scale Holdings Ltd
F:92N0
|
HK |
|
Pursuit Attractions and Hospitality Inc
NYSE:PRSU
|
US |
|
D
|
Dai Nippon Printing Co Ltd
F:DNP
|
JP |
|
E
|
Ebro Foods SA
DUS:AZU
|
ES |
|
G
|
Gap Inc
XMUN:GAP
|
US |
|
L
|
Lake Shore Bancorp Inc
NASDAQ:LSBK
|
US |
|
G
|
Genco Shipping & Trading Ltd
F:GNU1
|
US |
|
MegaPower Makmur Tbk PT
IDX:MPOW
|
ID |
|
A
|
Atrys Health SA
F:A2T
|
ES |
|
B
|
BioInvent International AB
STO:BINV
|
SE |
|
Lords & Company Worldwide Holdings Inc
F:4XM
|
CA |
|
M
|
Mitie Group PLC
OTC:MITFY
|
UK |
|
P
|
Pungguk Ethanol Co Ltd
KOSDAQ:023900
|
KR |
|
P
|
PagerDuty Inc
F:2TY
|
US |
|
Energeia AS
F:F620
|
NO |
|
I
|
Inchcape PLC
F:IJCA
|
UK |
|
A
|
Atrys Health SA
MAD:ATRY
|
ES |
|
Enghouse Systems Ltd
F:3E4
|
CA |
|
A
|
Acushnet Holdings Corp
F:163
|
US |
|
T
|
T S Flour Mill PCL
SET:TMILL
|
TH |
|
Savills PLC
LSE:SVS
|
UK |
Wall St Price Targets
XP0 Price Forecast
Based on 21 analysts
Based on 21 analysts
+134% Upside
from
€31.2
today
Xenon Pharmaceuticals Inc (XP0)’s 12-month stock price forecast through October 2027 has a consensus target of €72.91, implying 134% upside. The forecast is based on price targets from 21 Wall Street analysts.
Xenon Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XP0's stock price target?
Price Target
72.91
EUR
72.91
EUR
According to Wall Street analysts, the average 1-year price target for XP0 is 72.91 EUR with a low forecast of 45.49 EUR and a high forecast of 92.53 EUR.
What is the Revenue forecast for Xenon Pharmaceuticals Inc?
Projected CAGR
108%
108%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 8 years is 108%.